Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04097106 · ClinicalTrials.gov registry record
Synbiotic Dietary Supplement and Gut Microbiota
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 34
- Enrollment target
NCT04097106: Completed study, sponsored by The Cleveland Clinic.
NCT04097106 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04097106 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
To test the feasibility and safety of our designer synbiotic on gastrointestinal symptoms and gut microbiota and fecal metabolomics.
Primary Outcome
Rating of GI Symptoms scale includes 5 questions, which range from 0 (never affected) to 7 (always bothered), summed to compute total score
Interventions
- DIETARY_SUPPLEMENT Synbiotic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2020-11-10 |
| Est. Completion | 2022-06-27 |
What the finished NCT04097106 record still lists
NCT04097106 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Synbiotic is the first listed.
NCT04097106 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04097106 about?
NCT04097106 is a clinical study titled "Synbiotic Dietary Supplement and Gut Microbiota". To test the feasibility and safety of our designer synbiotic on gastrointestinal symptoms and gut microbiota and fecal metabolomics.
What is the current status of trial NCT04097106?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2020-11-10. Estimated completion is 2022-06-27.
What interventions are being tested in trial NCT04097106?
The interventions under investigation include: Synbiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04097106?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI